Who’s got $47.6 million in new financing?
That would be Apollo Endosurgery Inc. The Austin-based medical device maker announced that it has landed a big round of funding to develop its line of minimally invasive, scarless surgical procedures.
Apollo Endosurgery’s investors include Novo A/S, Remeditex Ventures, CPMG, Inc., PTV Sciences and H.I.G. BioVentures.
The company will use the money to launch its OverStitch Endoscopic Suturing System and other flexible surgical tools that allow surgeons to perform numerous procedures without making incisions into the patient’s skin.